Semma Therapeutics Appoints Mary Kay Fenton as Chief Financial Officer
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced…
Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Semma Therapeutics, Inc., a biotechnology company pioneering the curative use of stem cells in regenerative medicine, today announced…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the first two patients have been enrolled into The INSPIRE…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the first two patients have been enrolled into The INSPIRE…
Research platform enables biotech startups to outsource everything but the genius SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/fasterscience?src=hash" target="_blank"gt;#fastersciencelt;/agt;–Scientist.com, the world’s largest marketplace…
WOBURN, Mass.–(BUSINESS WIRE)–ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, today announced…
Led by M Ventures with participation by Waters Corporation, the financing will be used by Riffyn to meet surging demand…
ALBUQUERQUE, N.M.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/NCI?src=hash" target="_blank"gt;#NCIlt;/agt;–AgilVax, Inc., a biotechnology company developing targeted antibody-based therapies for the treatment of various cancers, including…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Imara, Inc., a clinical-stage biopharmaceutical company focused on sickle cell disease and other hemoglobinopathies, today announced that the…